308 related articles for article (PubMed ID: 27281823)
1. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia inducible factors regulate the transcription of the sprouty2 gene and expression of the sprouty2 protein.
Gao X; Hicks KC; Neumann P; Patel TB
PLoS One; 2017; 12(2):e0171616. PubMed ID: 28196140
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cellular levels of Sprouty2 protein by prolyl hydroxylase domain and von Hippel-Lindau proteins.
Anderson K; Nordquist KA; Gao X; Hicks KC; Zhai B; Gygi SP; Patel TB
J Biol Chem; 2011 Dec; 286(49):42027-42036. PubMed ID: 22006925
[TBL] [Abstract][Full Text] [Related]
4. Failure to prolyl hydroxylate hypoxia-inducible factor alpha phenocopies VHL inactivation in vivo.
Kim WY; Safran M; Buckley MR; Ebert BL; Glickman J; Bosenberg M; Regan M; Kaelin WG
EMBO J; 2006 Oct; 25(19):4650-62. PubMed ID: 16977322
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.
Rathmell WK; Hickey MM; Bezman NA; Chmielecki CA; Carraway NC; Simon MC
Cancer Res; 2004 Dec; 64(23):8595-603. PubMed ID: 15574766
[TBL] [Abstract][Full Text] [Related]
6. Formation of Renal Cysts and Tumors in Vhl/Trp53-Deficient Mice Requires HIF1α and HIF2α.
Schönenberger D; Harlander S; Rajski M; Jacobs RA; Lundby AK; Adlesic M; Hejhal T; Wild PJ; Lundby C; Frew IJ
Cancer Res; 2016 Apr; 76(7):2025-36. PubMed ID: 26759234
[TBL] [Abstract][Full Text] [Related]
7. A macrophage-dominant PI3K isoform controls hypoxia-induced HIF1α and HIF2α stability and tumor growth, angiogenesis, and metastasis.
Joshi S; Singh AR; Zulcic M; Durden DL
Mol Cancer Res; 2014 Oct; 12(10):1520-31. PubMed ID: 25103499
[TBL] [Abstract][Full Text] [Related]
8. Evolution of metazoan oxygen-sensing involved a conserved divergence of VHL affinity for HIF1α and HIF2α.
Tarade D; Lee JE; Ohh M
Nat Commun; 2019 Jul; 10(1):3293. PubMed ID: 31337753
[TBL] [Abstract][Full Text] [Related]
9. pVHL mediates K63-linked ubiquitination of nCLU.
Xue J; Lv DD; Jiao S; Zhao W; Li X; Sun H; Yan B; Fan L; Hu RG; Fang J
PLoS One; 2012; 7(4):e35848. PubMed ID: 22532874
[TBL] [Abstract][Full Text] [Related]
10. Homology modeling and molecular dynamics simulation of the HIF2α degradation-related HIF2α-VHL complex.
Dong X; Su X; Yu J; Liu J; Shi X; Pan Q; Yang J; Chen J; Li L; Cao H
J Mol Graph Model; 2017 Jan; 71():116-123. PubMed ID: 27902963
[TBL] [Abstract][Full Text] [Related]
11. RHOBTB3 promotes proteasomal degradation of HIFα through facilitating hydroxylation and suppresses the Warburg effect.
Zhang CS; Liu Q; Li M; Lin SY; Peng Y; Wu D; Li TY; Fu Q; Jia W; Wang X; Ma T; Zong Y; Cui J; Pu C; Lian G; Guo H; Ye Z; Lin SC
Cell Res; 2015 Sep; 25(9):1025-42. PubMed ID: 26215701
[TBL] [Abstract][Full Text] [Related]
12. Regulation of tyrosine hydroxylase promoter activity by the von Hippel-Lindau tumor suppressor protein and hypoxia-inducible transcription factors.
Schnell PO; Ignacak ML; Bauer AL; Striet JB; Paulding WR; Czyzyk-Krzeska MF
J Neurochem; 2003 Apr; 85(2):483-91. PubMed ID: 12675925
[TBL] [Abstract][Full Text] [Related]
13. USP9X destabilizes pVHL and promotes cell proliferation.
Zhang C; Peng Z; Zhu M; Wang P; Du X; Li X; Liu Y; Jin Y; McNutt MA; Yin Y
Oncotarget; 2016 Sep; 7(37):60519-60534. PubMed ID: 27517496
[TBL] [Abstract][Full Text] [Related]
14. Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner.
Todd VM; Vecchi LA; Clements ME; Snow KP; Ontko CD; Himmel L; Pinelli C; Rafat M; Johnson RW
Commun Biol; 2021 Sep; 4(1):1122. PubMed ID: 34556788
[TBL] [Abstract][Full Text] [Related]
15. Restricted expression of miR-30c-2-3p and miR-30a-3p in clear cell renal cell carcinomas enhances HIF2α activity.
Mathew LK; Lee SS; Skuli N; Rao S; Keith B; Nathanson KL; Lal P; Simon MC
Cancer Discov; 2014 Jan; 4(1):53-60. PubMed ID: 24189146
[TBL] [Abstract][Full Text] [Related]
16. Mutant versions of von Hippel-Lindau (VHL) can protect HIF1α from SART1-mediated degradation in clear-cell renal cell carcinoma.
Ordóñez-Navadijo Á; Fuertes-Yebra E; Acosta-Iborra B; Balsa E; Elorza A; Aragonés J; Landazuri MO
Oncogene; 2016 Feb; 35(5):587-94. PubMed ID: 25915846
[TBL] [Abstract][Full Text] [Related]
17. The functional interplay between the HIF pathway and the ubiquitin system - more than a one-way road.
Günter J; Ruiz-Serrano A; Pickel C; Wenger RH; Scholz CC
Exp Cell Res; 2017 Jul; 356(2):152-159. PubMed ID: 28315321
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of hypoxia-inducible factor is sufficient for growth suppression of VHL-/- tumors.
Zimmer M; Doucette D; Siddiqui N; Iliopoulos O
Mol Cancer Res; 2004 Feb; 2(2):89-95. PubMed ID: 14985465
[TBL] [Abstract][Full Text] [Related]
19. Vulnerability of HIF1α and HIF2α to damage by proteotoxic stressors.
Meyers LM; Krawic C; Luczak MW; Zhitkovich A
Toxicol Appl Pharmacol; 2022 Jun; 445():116041. PubMed ID: 35504338
[TBL] [Abstract][Full Text] [Related]
20. Identification of cyclin D1 and other novel targets for the von Hippel-Lindau tumor suppressor gene by expression array analysis and investigation of cyclin D1 genotype as a modifier in von Hippel-Lindau disease.
Zatyka M; da Silva NF; Clifford SC; Morris MR; Wiesener MS; Eckardt KU; Houlston RS; Richards FM; Latif F; Maher ER
Cancer Res; 2002 Jul; 62(13):3803-11. PubMed ID: 12097293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]